Skip to content
  • Sunday, 26 July 2026
  • 2:53 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Stanford Medicine Study Reveals Potential Breakthrough in Reversing Osteoarthritis Through Gerozyme Inhibition and Cartilage Regeneration
Stem Cell & Regenerative Medicine

Stanford Medicine Study Reveals Potential Breakthrough in Reversing Osteoarthritis Through Gerozyme Inhibition and Cartilage Regeneration

Dwi Wanna Jul 5, 2026 0

The landscape of regenerative medicine has shifted following a landmark study led by Stanford Medicine researchers, which demonstrates that targeting…

Read More
Neuroscience & Brain Research

Placebo Treatments Show Significant Potential in Enhancing Physical and Cognitive Function Among Older Adults

Rifan Muazin Jul 5, 2026 0

New clinical evidence suggests that the mere act of engaging in a treatment regimen, even one devoid of active pharmacological…

Read More
Pharmaceutical R&D

Bocunebart’s PACAP-Targeting Mechanism Positions it as a Potential First-in-Class Therapy in a Thin Pipeline of Novel Late-Stage Candidates

Teuku Ryan Jul 2, 2026 0

New Data Unveiled for Bocunebart, a Promising Migraine Preventive Targeting a Novel Pathway Munich, Germany – June 29, 2026 –…

Read More
Pharmaceutical R&D

Sanofi’s Nexviazyme Demonstrates Promising Results in Infants with Infantile-Onset Pompe Disease, Paving Way for Potential Label Expansion

Teuku Ryan Jul 1, 2026 0

Sanofi’s groundbreaking treatment for Pompe disease, Nexviazyme (avalglucosidase alfa), has achieved a significant milestone with the successful completion of the…

Read More
Laboratory Automation & Robotics

Traumatic brain injury and Alzheimer’s disease: Common neuroinflammatory pathologies and therapeutic potential

Lana Keisha Jun 26, 2026 0

Traumatic brain injury (TBI) stands as a formidable global health challenge, impacting an estimated 69 million individuals annually across all…

Read More
Neuroscience & Brain Research

Monash University Researchers Identify Copper-Based Drug as Potential Breakthrough in Alzheimer’s Treatment by Restoring Brain Waste Removal Systems

Rifan Muazin Jun 25, 2026 0

A team of researchers at Monash University has unveiled a significant discovery that could redefine the therapeutic landscape for Alzheimer’s…

Read More
Molecular & Cell Biology

A Tiny Genetic Change in Animal Viruses May Hold the Key to Understanding Human Pandemic Potential

Angie Faith Jun 25, 2026 0

The emergence of novel infectious diseases, often characterized by the jump of pathogens from animal populations to humans, has become…

Read More
Neuroscience & Brain Research

Ancient Brainstem Circuit Identified as Key Driver of Selective Attention and Potential Link to ADHD

Rifan Muazin Jun 25, 2026 0

Neuroscientists at Johns Hopkins University have identified a specialized group of neurons within an evolutionarily ancient region of the brain…

Read More
Advanced Materials Science

Quantum Sensing Breakthrough at University at Buffalo Promises to Unlock the Potential of Altermagnets for Next-Generation Electronics

Nila Kartika Wati Jun 24, 2026 0

In a significant advancement for the field of condensed matter physics, researchers at the University at Buffalo have unveiled a…

Read More
Stem Cell & Regenerative Medicine

Scientists Identify Liquid Condensate Mechanism Driving Rare Kidney Cancer and Potential New Treatment Pathways

Dwi Wanna Jun 23, 2026 0

A collaborative research effort led by scientists at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins Bloomberg School…

Read More

Posts pagination

1 2 3 … 9
Novo Nordisk Sues Hims for GLP-1 Patent InfringementJohns Hopkins Study Reveals Significant Cardiac Weakening and Molecular Changes in Bioengineered Heart Tissues After Month Long Space Station MissionInnovative Viciazite Materials Offer Low-Energy Pathway for Industrial Carbon Capture and Climate MitigationTubulin Identified as a Critical Molecular Safeguard Against Neurodegenerative Protein Aggregation in Alzheimer’s and Parkinson’s Diseases
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ